Omar Barakat, MD, FRCS
See Publications

Education

  • Medical School:

    Aleppo University Medical School

  • Residency:

    Aleppo University Hospital
    Medical College of Pennsylvania (General Surgery)

  • Fellowships:

    The University of Texas Medical School at Houston (Transplant Surgery)
    The Texas Heart Institute (Heart Transplantation and Mechanical Assist Devices)
    State University of New York (Cardiovascular Surgery Research)

Academic & Clinical Affiliations

Honors, Awards and Memberships

Publications

4862227 ALPULI85 1 alternatives-to-animal-experimentation 10 date desc Barakat 53900 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22T7TLYZI8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Manisundaram%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BManisundaram%2C%20N.%2C%20Portuondo%2C%20J.%20I.%2C%20Erstad%2C%20D.%20et%20al.%20%282023%29.%20Pretreatment%20Health-Related%20Quality-of-Life%20Status%20and%20Survival%20in%20Pancreatobiliary%20Surgical%20Patients.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B236%26lt%3B%5C%2Fi%26gt%3B%2C%20861%26%23x2013%3B870.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FXCS.0000000000000549%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FXCS.0000000000000549%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pretreatment%20Health-Related%20Quality-of-Life%20Status%20and%20Survival%20in%20Pancreatobiliary%20Surgical%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naveen%22%2C%22lastName%22%3A%22Manisundaram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20I.%22%2C%22lastName%22%3A%22Portuondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%22%2C%22lastName%22%3A%22Erstad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Navarro-Cagigas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Ramsay%22%2C%22lastName%22%3A%22Camp%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Pancreatobiliary%20%28PB%29%20disorders%2C%20especially%20cancer%2C%20negatively%20affect%20patients%26%23039%3B%20health-related%20quality%20of%20life%20%28HRQoL%29.%20However%2C%20the%20influence%20of%20baseline%2C%20preintervention%20HRQoL%20on%20perioperative%20and%20oncologic%20outcomes%20has%20not%20been%20well%20defined.%20We%20hypothesized%20that%20low%20baseline%20HRQoL%20is%20associated%20with%20worse%20perioperative%20and%20long-term%20survival%20outcomes%20for%20PB%20surgical%20patients.%5CnSTUDY%20DESIGN%3A%20Pretreatment%20Functional%20Assessment%20of%20Cancer%20Therapy%20-%20Hepatobiliary%20Survey%20results%20and%20clinical%20data%20from%20PB%20patients%20%282008%20to%202016%29%20from%20a%20single%20center%26%23039%3Bs%20prospective%20database%20were%20analyzed.%20Survey%20responses%20were%20aggregated%20into%20composite%20scores%20and%20divided%20into%20quintiles.%20Patients%20in%20the%20highest%20quintile%20of%20HRQoL%20were%20compared%20to%20patients%20in%20the%20bottom%20four%20quintiles%20combined.%20Overall%20survival%20%28OS%29%20and%20disease-free%20survival%20%28DFS%29%20were%20analyzed%20using%20the%20Kaplan-Meier%20method.%20Logistic%20and%20Cox%20regressions%20were%20used%20to%20determine%20associations%20between%20quintiles%20of%20HRQoL%20scores%20and%2030-day%20complications%20and%20long-term%20survival%2C%20respectively.%5CnRESULTS%3A%20Of%20162%20patients%20evaluated%2C%2099%20had%20malignancy%2C%20and%2063%20had%20benign%20disease.%20Median%20follow-up%20was%2031%20months.%20Baseline%20HRQoL%20scores%20were%20similar%20for%20benign%20and%20malignant%20disease%20%28p%20%3D%200.42%29%20and%20were%20not%20associated%20with%20the%20development%20of%20any%20%28p%20%3D%200.08%29%20or%20major%20complications%20%28p%20%3D%200.64%29.%20Patients%20with%20highest%20quintile%20HRQoL%20scores%20had%20improved%203-year%20OS%20%2884.6%20vs%2061.7%25%2C%20p%20%3D%200.03%29%20compared%20to%20patients%20in%20the%20lowest%20four%20quintiles%20of%20HRQoL.%20Among%20cancer%20patients%20only%2C%20those%20with%20the%20highest%20quintile%20scores%20had%20improved%203-year%20OS%20%2881.6%20vs%2047.4%25%2C%20p%20%3D%200.02%29.%20On%20multivariable%20analysis%2C%20highest%20quintile%20HRQoL%20scores%20were%20associated%20with%20longer%20OS%20and%20DFS%20for%20patients%20with%20malignancy.%5CnCONCLUSIONS%3A%20Pretreatment%20HRQoL%20was%20associated%20with%20both%20OS%20and%20DFS%20among%20PB%20patients%20and%20might%20have%20prognostic%20utility.%20Future%20studies%20are%20necessary%20to%20determine%20whether%20patients%20with%20poorer%20HRQoL%20may%20benefit%20from%20targeted%20psychosocial%20interventions.%22%2C%22date%22%3A%222023-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FXCS.0000000000000549%22%2C%22ISSN%22%3A%221879-1190%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A56%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22KZIT2M7V%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Michelakos%20et%20al.%22%2C%22parsedDate%22%3A%222021-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMichelakos%2C%20T.%2C%20Kontos%2C%20F.%2C%20%26lt%3Bstrong%26gt%3BBarakat%26lt%3B%5C%2Fstrong%26gt%3B%2C%20O.%20et%20al.%20%282021%29.%20B7-H3%20targeted%20antibody-based%20immunotherapy%20of%20malignant%20diseases.%20%26lt%3Bi%26gt%3BExpert%20Opin%20Biol%20Ther%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20587%26%23x2013%3B602.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14712598.2021.1862791%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14712598.2021.1862791%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22B7-H3%20targeted%20antibody-based%20immunotherapy%20of%20malignant%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodoros%22%2C%22lastName%22%3A%22Michelakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filippos%22%2C%22lastName%22%3A%22Kontos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Maggs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20H.%22%2C%22lastName%22%3A%22Schwab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20R.%22%2C%22lastName%22%3A%22Ferrone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soldano%22%2C%22lastName%22%3A%22Ferrone%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Recent%20advances%20in%20immuno-oncology%20and%20bioengineering%20have%20rekindled%20the%20interest%20in%20monoclonal%20antibody%20%28mAb%29-based%20immunotherapies%20for%20malignancies.%20Crucial%20for%20their%20success%20is%20the%20identification%20of%20tumor%20antigens%20%28TAs%29%20that%20can%20serve%20as%20targets.%20B7-H3%2C%20a%20member%20of%20the%20B7%20ligand%20family%2C%20represents%20such%20a%20TA.%20Although%20its%20exact%20functions%20and%20receptor%28s%29%20remain%20unclear%2C%20B7-H3%20has%20predominantly%20a%20pro-tumorigenic%20effect%20mainly%20by%20suppressing%20the%20anti-tumor%20functions%20of%20T-cells.Areas%20covered%3A%20Initially%20we%20present%20a%20historical%20perspective%20on%20TA-specific%20antibodies%20for%20diagnosis%20and%20treatment%20of%20malignancies.%20Following%20a%20description%20of%20the%20TA%20requirements%20to%20be%20an%20attractive%20antibody-based%20immunotherapy%20target%2C%20we%20show%20that%20B7-H3%20fulfills%20these%20criteria.%20We%20discuss%20its%20structure%20and%20functions.%20In%20a%20review%20and%20pooled%20analysis%2C%20we%20describe%20the%20limited%20B7-H3%20expression%20in%20normal%20tissues%20and%20estimate%20B7-H3%20expression%20frequency%20in%20tumors%2C%20tumor-associated%20vasculature%20and%20cancer%20initiating%20cells%20%28CICs%29.%20Lastly%2C%20we%20discuss%20the%20association%20of%20B7-H3%20expression%20in%20tumors%20with%20poor%20prognosis.Expert%20opinion%3A%20B7-H3%20is%20an%20attractive%20target%20for%20mAb-based%20cancer%20immunotherapy.%20B7-H3-targeting%20strategies%20are%20expected%20to%20be%20highly%20effective%20and%20-%20importantly%20-%20safe.%20To%20fully%20exploit%20the%20diagnostic%20and%20therapeutic%20potential%20of%20B7-H3%2C%20its%20expression%20in%20pre-malignant%20lesions%2C%20serum%2C%20metastases%2C%20and%20CICs%20requires%20further%20investigation.%22%2C%22date%22%3A%222021-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F14712598.2021.1862791%22%2C%22ISSN%22%3A%221744-7682%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A56%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22TVKWZ4HL%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Haider%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHaider%2C%20M.%20A.%2C%20Naqvi%2C%20S.%2C%20%26lt%3Bstrong%26gt%3BBarakat%26lt%3B%5C%2Fstrong%26gt%3B%2C%20O.%20et%20al.%20%282021%29.%20Ampullary%20Carcinosarcoma%20with%20Enteroblastic%20Differentiation%3A%20A%20Case%20Report.%20%26lt%3Bi%26gt%3BAnn%20Clin%20Lab%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%20131%26%23x2013%3B135%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ampullary%20Carcinosarcoma%20with%20Enteroblastic%20Differentiation%3A%20A%20Case%20Report%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%20Adnan%22%2C%22lastName%22%3A%22Haider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shagufta%22%2C%22lastName%22%3A%22Naqvi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20Elizabeth%22%2C%22lastName%22%3A%22Wilken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadhna%22%2C%22lastName%22%3A%22Dhingra%22%7D%5D%2C%22abstractNote%22%3A%22Adenocarcinoma%20with%20enteroblastic%20differentiation%20is%20an%20extremely%20rare%20tumor%20with%20poor%20prognosis%20and%20unique%20pathologic%20features.%20The%20tumor%20appears%20to%20be%20relatively%20more%20common%20in%20stomach%2C%20with%20rare%20cases%20reported%20in%20esophagus%2C%20colon%2C%20rectum%20and%20ampulla.%20Underrecognition%20by%20pathologists%20may%20be%20a%20contributing%20factor%20towards%20underreporting%20of%20this%20tumor.%20Combination%20of%20carcinosarcoma%20and%20enteroblastic%20differentiation%20has%20not%20been%20reported%20so%20far.We%20report%20a%20unique%20case%20of%20ampullary%20carcinosarcoma%20with%20enteroblastic%20differentiation%20in%20a%2059-year-old%20female%2C%20diagnosed%20in%20the%20pancreatoduodenectomy%20specimen.%20The%20carcinomatous%20component%20showed%20features%20of%20enteroblastic%20differentiation%20characterized%20by%20tubular%20architecture%20with%20clear%20cytoplasm%2C%20solid%20component%20with%20trabecular%20architecture%20and%20immunohistochemical%20expression%20of%20SALL4%20and%20AFP.%20The%20patient%20was%20treated%20with%20adjuvant%20Folfirinox%20chemotherapy%20and%20is%20disease%20free%20at%2017%20months%20follow%20up.%22%2C%22date%22%3A%222021-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221550-8080%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A56%3A55Z%22%7D%7D%2C%7B%22key%22%3A%226MFSKLTQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Villafane-Ferriol%20et%20al.%22%2C%22parsedDate%22%3A%222019-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVillafane-Ferriol%2C%20N.%2C%20Baugh%2C%20K.%20A.%2C%20McElhany%2C%20A.%20L.%20et%20al.%20%282019%29.%20Evidence%20versus%20practice%20in%20early%20drain%20removal%20after%20pancreatectomy.%20%26lt%3Bi%26gt%3BJ%20Surg%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B236%26lt%3B%5C%2Fi%26gt%3B%2C%20332%26%23x2013%3B339.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2018.11.048%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2018.11.048%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evidence%20versus%20practice%20in%20early%20drain%20removal%20after%20pancreatectomy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Villafane-Ferriol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Baugh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20L.%22%2C%22lastName%22%3A%22McElhany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erisha%20K.%22%2C%22lastName%22%3A%22Tashakori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20E.%20Mendez%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hop%20S.%20Tran%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nader%22%2C%22lastName%22%3A%22Massarweh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Zyromski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Dillhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20A.%22%2C%22lastName%22%3A%22Villarreal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Early%20drain%20removal%20when%20postoperative%20day%20%28POD%29%20one%20drain%20fluid%20amylase%20%28DFA%29%20was%20%5Cu22645000%20U%5C%2FL%20reduced%20complications%20in%20a%20previous%20randomized%20controlled%20trial.%20We%20hypothesized%20that%20most%20surgeons%20continue%20to%20remove%20drains%20late%20and%20this%20is%20associated%20with%20inferior%20outcomes.%5CnMETHODS%3A%20We%20assessed%20the%20practice%20of%20surgeons%20in%20a%20prospectively%20maintained%20pancreas%20surgery%20registry%20to%20determine%20the%20association%20between%20timing%20of%20drain%20removal%20with%20demographics%2C%20comorbidities%2C%20and%20complications.%20We%20selected%20patients%20with%20POD1%20DFA%20%5Cu22645000%20U%5C%2FL%20and%20excluded%20those%20without%20drains%2C%20and%20subjects%20without%20data%20on%20POD1%20DFA%20or%20timing%20of%20drain%20removal.%20Early%20drain%20removal%20was%20defined%20as%5Cu00a0%5Cu2264%5Cu00a0POD5.%5CnRESULTS%3A%20Two%20hundred%20and%20forty%20four%20patients%20met%20inclusion%20criteria.%20Only%2090%20%2837%25%29%20had%20drains%20removed%20early.%20Estimated%20blood%20loss%20was%20greater%20in%20the%20late%20removal%20group%20%28190%5Cu00a0mL%20versus%20100%5Cu00a0mL%2C%20P%5Cu00a0%3D%5Cu00a00.005%29%20and%20pathological%20findings%20associated%20with%20soft%20gland%20texture%20were%20more%20frequent%20%2897%20%5B63%25%5D%20versus%2035%20%5B39%25%5D%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.0001%29.%20Patients%20in%20the%20late%20drain%20removal%20group%20had%20more%20complications%20%2884%20%5B55%25%5D%20versus%2030%20%5B33%25%5D%2C%20P%5Cu00a0%3D%5Cu00a00.001%29%20including%20pancreatic%20fistula%20%2855%20%5B36%25%5D%20versus%204%20%5B4%25%5D%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.0001%29%2C%20delayed%20gastric%20emptying%20%2827%20%5B18%25%5D%20versus%203%20%5B3%25%5D%2C%20P%5Cu00a0%3D%5Cu00a00.002%29%2C%20and%20longer%20length%20of%20stay%20%287%5Cu00a0d%20versus%205%5Cu00a0d%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.0001%29.%20In%20subset%20analysis%20for%20procedure%20type%2C%5Cu00a0complications%20and%20pancreatic%20fistula%20remained%20significant%20for%20both%20pancreatoduodenectomy%20and%20distal%20pancreatectomy.%5CnCONCLUSIONS%3A%20Despite%20level%20one%20data%20suggesting%20improved%20outcomes%20with%20early%20removal%20when%20POD1%20DFA%20is%5Cu00a0%5Cu2264%5Cu00a05000%20U%5C%2FL%2C%20experienced%20pancreas%20surgeons%20more%20frequently%20removed%20drains%20late.%20This%20practice%20was%20associated%20with%20known%20risk%20factors%20%28estimated%20blood%20loss%2C%20soft%20pancreas%29%20and%20may%20be%20associated%20with%20inferior%20outcomes%20suggesting%20potential%20for%20improvement.%22%2C%22date%22%3A%22Apr%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jss.2018.11.048%22%2C%22ISSN%22%3A%221095-8673%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A58%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22C6XKY6AN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Baugh%20et%20al.%22%2C%22parsedDate%22%3A%222019-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBaugh%2C%20K.%20A.%2C%20Tran%20Cao%2C%20H.%20S.%2C%20van%20Buren%2C%20G.%20et%20al.%20%282019%29.%20Understaging%20of%20clinical%20stage%20I%20pancreatic%20cancer%20and%20the%20impact%20of%20multimodality%20therapy.%20%26lt%3Bi%26gt%3BSurgery%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B165%26lt%3B%5C%2Fi%26gt%3B%2C%20307%26%23x2013%3B314.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.surg.2018.08.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.surg.2018.08.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Understaging%20of%20clinical%20stage%20I%20pancreatic%20cancer%20and%20the%20impact%20of%20multimodality%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Baugh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hop%20S.%22%2C%22lastName%22%3A%22Tran%20Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christy%22%2C%22lastName%22%3A%22Chai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nader%20N.%22%2C%22lastName%22%3A%22Massarweh%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%20current%20guidelines%20recommend%20multimodal%20therapy%20for%20all%20patients%20with%20pancreatic%20ductal%20adenocarcinoma%2C%20it%20is%20unclear%20the%20extent%20to%20which%20clinical%20stage%20I%20patients%20are%20accurately%20staged%20and%20how%20this%20may%20affect%20management.%5CnMETHODS%3A%20In%20this%20retrospective%20cohort%20study%20of%204%2C404%20patients%20aged%2018-79%20years%20with%20clinical%20stage%201%20%28ie%2C%20T1N0%20or%20T2N0%29%20pancreatic%20ductal%20adenocarcinoma%20treated%20with%20upfront%20resection%20in%20the%20National%20Cancer%20Database%20%282004-2014%29%2C%20understaging%20was%20ascertained%20by%20comparing%20pretreatment%20clinical%20stage%20with%20pathologic%20stage.%20The%20association%20between%20adjuvant%20treatment%20and%20overall%20risk%20of%20death%20among%20true%20stage%20I%20and%20understaged%20patients%20was%20evaluated%20using%20multivariable%20Cox%20regression.%5CnRESULTS%3A%20Upstaging%20was%20identified%20in%2072.6%25%20of%20patients%20%2862.8%25%20T3%5C%2F4%2C%2053.9%25%20N1%29%20of%20whom%2069.7%25%20received%20adjuvant%20therapy%20compared%20with%2047.0%25%20with%20true%20stage%20I%20disease.%20Overall%20survival%20at%205%20years%20among%20those%20with%20true%20stage%20I%20disease%20was%20significantly%20higher%20than%20those%20who%20had%20been%20clinically%20understaged%20%2842.9%25%20vs%2016.6%25%3B%20log-rank%2C%20p%5Cu202f%26lt%3B%5Cu202f0.001%29.%20For%20true%20stage%20I%20patients%2C%20adjuvant%20therapy%20was%20not%20associated%20with%20risk%20of%20death%20%28hazard%20ratio%3A%201.07%2C%2095%25%20confidence%20interval%3A%200.89-1.29%29.%20For%20understaged%20patients%2C%20adjuvant%20therapy%20significantly%20decreased%20risk%20of%20death%20%28hazard%20ratio%3A%200.64%2C%2095%25%20confidence%20interval%3A%200.55-0.74%29.%5CnCONCLUSION%3A%20The%20majority%20of%20clinical%20stage%20I%20pancreatic%20ductal%20adenocarcinoma%20patients%20actually%20have%20higher-stage%20disease%20and%20benefit%20from%20multimodal%20therapy%3B%20however%2C%20one%20third%20of%20understaged%20patients%20do%20not%20receive%20any%20adjuvant%20treatment.%20Clinicians%20should%20discuss%20all%20potential%20treatment%20strategies%20with%20patients%20%28in%20the%20context%20of%20the%20acknowledged%20risks%20and%20benefits%29%2C%20including%20the%20utilization%20of%20neoadjuvant%20approaches%20in%20those%20presenting%20with%20potentially%20resectable%20disease.%22%2C%22date%22%3A%22Feb%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.surg.2018.08.003%22%2C%22ISSN%22%3A%221532-7361%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%2C%22X5EBXL9Y%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A57%3A36Z%22%7D%7D%2C%7B%22key%22%3A%229TDYSDJW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Villafane-Ferriol%20et%20al.%22%2C%22parsedDate%22%3A%222018-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVillafane-Ferriol%2C%20N.%2C%20Shah%2C%20R.%20M.%2C%20Mohammed%2C%20S.%20et%20al.%20%282018%29.%20Evidence-based%20management%20of%20drains%20following%20pancreatic%20resection%3A%20a%20systematic%20review.%20%26lt%3Bi%26gt%3BPancreas%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%2012%26%23x2013%3B17.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMPA.0000000000000961%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMPA.0000000000000961%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evidence-based%20management%20of%20drains%20following%20pancreatic%20resection%3A%20a%20systematic%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Villafane-Ferriol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%20M.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somala%22%2C%22lastName%22%3A%22Mohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nader%20N.%22%2C%22lastName%22%3A%22Massarweh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hop%20S.%22%2C%22lastName%22%3A%22Tran%20Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%5D%2C%22abstractNote%22%3A%22Many%20pancreatic%20surgeons%20continue%20to%20use%20intraperitoneal%20drains%2C%20but%20others%20have%20limited%20or%20avoided%20their%20use%2C%20believing%20this%20improves%20outcomes.%20We%20conducted%20a%20systematic%20review%20and%20meta-analysis%20of%20the%20literature%20assessing%20outcomes%20in%20pancreatectomy%20without%20drains%2C%20selective%20drainage%2C%20and%20early%20drain%20removal.%20We%20searched%20PubMed%2C%20Embase%2C%20and%20the%20Cochrane%20Library%20databases%20and%20conducted%20a%20systematic%20review%20of%20randomized%20and%20nonrandomized%20studies%20comparing%20routine%20intra-abdominal%20drainage%20versus%20no%20drainage%2C%20selective%20drain%20use%2C%20and%20early%20versus%20late%20drain%20removal%20after%20pancreatectomy%2C%20with%20major%20complications%20as%20the%20primary%20outcome.%20A%20meta-analysis%20of%20the%20literature%20assessing%20routine%20use%20of%20drains%20was%20conducted%20using%20the%20random-effects%20model.%20A%20total%20of%20461%20articles%20met%20search%20criteria%20from%20PubMed%20%28168%20articles%29%2C%20Embase%20%28263%20articles%29%2C%20and%20the%20Cochrane%20Library%20%2830%20articles%29.%20After%20case%20reports%20and%20articles%20without%20primary%20data%20on%20complications%20were%20excluded%2C%2014%20studies%20were%20identified%20for%20systematic%20review.%20Definitive%20evidence-based%20recommendations%20cannot%20be%20made%20regarding%20the%20management%20of%20drains%20following%20pancreatectomy%20because%20of%20limitations%20in%20the%20available%20literature.%20Based%20on%20available%20evidence%2C%20the%20most%20conservative%20approach%2C%20pending%20further%20data%2C%20is%20routine%20placement%20of%20a%20drain%20and%20early%20removal%20unless%20the%20patient%26%23039%3Bs%20clinical%20course%20or%20drain%20fluid%20amylase%20concentration%20suggests%20a%20developing%20fistula.%22%2C%22date%22%3A%22Jan%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMPA.0000000000000961%22%2C%22ISSN%22%3A%221536-4828%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A58%3A23Z%22%7D%7D%2C%7B%22key%22%3A%222BZP8AWZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Van%20Buren%20et%20al.%22%2C%22parsedDate%22%3A%222017-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVan%20Buren%2C%20G.%2C%20Bloomston%2C%20M.%2C%20Schmidt%2C%20C.%20R.%20et%20al.%20%282017%29.%20A%20Prospective%20Randomized%20Multicenter%20Trial%20of%20Distal%20Pancreatectomy%20With%20and%20Without%20Routine%20Intraperitoneal%20Drainage.%20%26lt%3Bi%26gt%3BAnn%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B266%26lt%3B%5C%2Fi%26gt%3B%2C%20421%26%23x2013%3B431.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000002375%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000002375%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Prospective%20Randomized%20Multicenter%20Trial%20of%20Distal%20Pancreatectomy%20With%20and%20Without%20Routine%20Intraperitoneal%20Drainage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Bloomston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%20R.%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20W.%22%2C%22lastName%22%3A%22Behrman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Zyromski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chad%20G.%22%2C%22lastName%22%3A%22Ball%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Karanicolas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20D.%22%2C%22lastName%22%3A%22Allendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20M.%22%2C%22lastName%22%3A%22Vollmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quan%22%2C%22lastName%22%3A%22Ly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%20M.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vic%22%2C%22lastName%22%3A%22Velanovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20M.%22%2C%22lastName%22%3A%22Winter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20L.%22%2C%22lastName%22%3A%22McElhany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Muscarella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%20Max%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20G.%22%2C%22lastName%22%3A%22House%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elijah%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20E.%22%2C%22lastName%22%3A%22Dillhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20G.%22%2C%22lastName%22%3A%22Trevino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Hallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20S.%20G.%22%2C%22lastName%22%3A%22Coburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Attila%22%2C%22lastName%22%3A%22Nakeeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20E.%22%2C%22lastName%22%3A%22Behrns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20R.%22%2C%22lastName%22%3A%22Sasson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20P.%22%2C%22lastName%22%3A%22Ceppa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherif%20R.%20Z.%22%2C%22lastName%22%3A%22Abdel-Misih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taylor%20S.%22%2C%22lastName%22%3A%22Riall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%20C.%22%2C%22lastName%22%3A%22Ellison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20B.%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hop%20S.%22%2C%22lastName%22%3A%22Tran%20Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somala%22%2C%22lastName%22%3A%22Mohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Villafa%5Cu00f1e-Ferriol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nader%20N.%22%2C%22lastName%22%3A%22Massarweh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christy%22%2C%22lastName%22%3A%22Chai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20E.%22%2C%22lastName%22%3A%22Mendez-Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eunji%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianxing%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20objective%20of%20this%20study%20was%20to%20test%20the%20hypothesis%20that%20distal%20pancreatectomy%20%28DP%29%20without%20intraperitoneal%20drainage%20does%20not%20affect%20the%20frequency%20of%20grade%202%20or%20higher%20grade%20complications.%5CnBACKGROUND%3A%20The%20use%20of%20routine%20intraperitoneal%20drains%20during%20DP%20is%20controversial.%20Prior%20to%20this%20study%2C%20no%20prospective%20trial%20focusing%20on%20DP%20without%20intraperitoneal%20drainage%20has%20been%20reported.%5CnMETHODS%3A%20Patients%20undergoing%20DP%20for%20all%20causes%20at%2014%20high-volume%20pancreas%20centers%20were%20preoperatively%20randomized%20to%20placement%20of%20a%20drain%20or%20no%20drain.%20Complications%20and%20their%20severity%20were%20tracked%20for%2060%20days%20and%20mortality%20for%2090%20days.%20The%20study%20was%20powered%20to%20detect%20a%2015%25%20positive%20or%20negative%20difference%20in%20the%20rate%20of%20grade%202%20or%20higher%20grade%20complications.%20All%20data%20were%20collected%20prospectively%20and%20source%20documents%20were%20reviewed%20at%20the%20coordinating%20center%20to%20confirm%20completeness%20and%20accuracy.%5CnRESULTS%3A%20A%20total%20of%20344%20patients%20underwent%20DP%20with%20%28N%20%3D%20174%29%20and%20without%20%28N%20%3D%20170%29%20the%20use%20of%20intraperitoneal%20drainage.%20There%20were%20no%20differences%20between%20cohorts%20in%20demographics%2C%20comorbidities%2C%20pathology%2C%20pancreatic%20duct%20size%2C%20pancreas%20texture%2C%20or%20operative%20technique.%20There%20was%20no%20difference%20in%20the%20rate%20of%20grade%202%20or%20higher%20grade%20complications%20%2844%25%20vs.%2042%25%2C%20P%20%3D%200.80%29.%20There%20was%20no%20difference%20in%20clinically%20relevant%20postoperative%20pancreatic%20fistula%20%2818%25%20vs%2012%25%2C%20P%20%3D%200.11%29%20or%20mortality%20%280%25%20vs%201%25%2C%20P%20%3D%200.24%29.%20DP%20without%20routine%20intraperitoneal%20drainage%20was%20associated%20with%20a%20higher%20incidence%20of%20intra-abdominal%20fluid%20collection%20%289%25%20vs%2022%25%2C%20P%20%3D%200.0004%29.%20There%20was%20no%20difference%20in%20the%20frequency%20of%20postoperative%20imaging%2C%20percutaneous%20drain%20placement%2C%20reoperation%2C%20readmission%2C%20or%20quality%20of%20life%20scores.%5CnCONCLUSIONS%3A%20This%20prospective%20randomized%20multicenter%20trial%20provides%20evidence%20that%20clinical%20outcomes%20are%20comparable%20in%20DP%20with%20or%20without%20intraperitoneal%20drainage.%22%2C%22date%22%3A%22Sep%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FSLA.0000000000002375%22%2C%22ISSN%22%3A%221528-1140%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A58%3A21Z%22%7D%7D%2C%7B%22key%22%3A%226XYNW5FT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gilliland%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGilliland%2C%20T.%20M.%2C%20Villafane-Ferriol%2C%20N.%2C%20Shah%2C%20K.%20P.%20et%20al.%20%282017%29.%20Nutritional%20and%20Metabolic%20Derangements%20in%20Pancreatic%20Cancer%20and%20Pancreatic%20Resection.%20%26lt%3Bi%26gt%3BNutrients%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fnu9030243%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fnu9030243%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nutritional%20and%20Metabolic%20Derangements%20in%20Pancreatic%20Cancer%20and%20Pancreatic%20Resection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taylor%20M.%22%2C%22lastName%22%3A%22Gilliland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Villafane-Ferriol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20P.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%20M.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hop%20S.%22%2C%22lastName%22%3A%22Tran%20Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nader%20N.%22%2C%22lastName%22%3A%22Massarweh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20A.%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cary%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20L.%22%2C%22lastName%22%3A%22McElhany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%5D%2C%22abstractNote%22%3A%22Pancreatic%20cancer%20is%20an%20aggressive%20malignancy%20with%20a%20poor%20prognosis.%20The%20disease%20and%20its%20treatment%20can%20cause%20significant%20nutritional%20impairments%20that%20often%20adversely%20impact%20patient%20quality%20of%20life%20%28QOL%29.%20The%20pancreas%20has%20both%20exocrine%20and%20endocrine%20functions%20and%2C%20in%20the%20setting%20of%20cancer%2C%20both%20systems%20may%20be%20affected.%20Pancreatic%20exocrine%20insufficiency%20%28PEI%29%20manifests%20as%20weight%20loss%20and%20steatorrhea%2C%20while%20endocrine%20insufficiency%20may%20result%20in%20diabetes%20mellitus.%20Surgical%20resection%2C%20a%20central%20component%20of%20pancreatic%20cancer%20treatment%2C%20may%20induce%20or%20exacerbate%20these%20dysfunctions.%20Nutritional%20and%20metabolic%20dysfunctions%20in%20patients%20with%20pancreatic%20cancer%20lack%20characterization%2C%20and%20few%20guidelines%20exist%20for%20nutritional%20support%20in%20patients%20after%20surgical%20resection.%20We%20reviewed%20publications%20from%20the%20past%20two%20decades%20%281995-2016%29%20addressing%20the%20nutritional%20and%20metabolic%20status%20of%20patients%20with%20pancreatic%20cancer%2C%20grouping%20them%20into%20status%20at%20the%20time%20of%20diagnosis%2C%20status%20at%20the%20time%20of%20resection%2C%20and%20status%20of%20nutritional%20support%20throughout%20the%20diagnosis%20and%20treatment%20of%20pancreatic%20cancer.%20Here%2C%20we%20summarize%20the%20results%20of%20these%20investigations%20and%20evaluate%20the%20effectiveness%20of%20various%20types%20of%20nutritional%20support%20in%20patients%20after%20pancreatectomy%20for%20pancreatic%20adenocarcinoma%20%28PDAC%29.%20We%20outline%20the%20following%20conservative%20perioperative%20strategies%20to%20optimize%20patient%20outcomes%20and%20guide%20the%20care%20of%20these%20patients%3A%20%281%29%20patients%20with%20albumin%20%26lt%3B%202.5%20mg%5C%2FdL%20or%20weight%20loss%20%26gt%3B%2010%25%20should%20postpone%20surgery%20and%20begin%20aggressive%20nutrition%20supplementation%3B%20%282%29%20patients%20with%20albumin%20%26lt%3B%203%20mg%5C%2FdL%20or%20weight%20loss%20between%205%25%20and%2010%25%20should%20have%20nutrition%20supplementation%20prior%20to%20surgery%3B%20%283%29%20enteral%20nutrition%20%28EN%29%20should%20be%20preferred%20as%20a%20nutritional%20intervention%20over%20total%20parenteral%20nutrition%20%28TPN%29%20postoperatively%3B%20and%2C%20%284%29%20a%20multidisciplinary%20approach%20should%20be%20used%20to%20allow%20for%20early%20detection%20of%20symptoms%20of%20endocrine%20and%20exocrine%20pancreatic%20insufficiency%20alongside%20implementation%20of%20appropriate%20treatment%20to%20improve%20the%20patient%26%23039%3Bs%20quality%20of%20life.%22%2C%22date%22%3A%22Mar%2007%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fnu9030243%22%2C%22ISSN%22%3A%222072-6643%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A58%3A13Z%22%7D%7D%2C%7B%22key%22%3A%225YFD6R7H%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barakat%20et%20al.%22%2C%22parsedDate%22%3A%222016-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BBarakat%26lt%3B%5C%2Fstrong%26gt%3B%2C%20O.%2C%20Cagigas%2C%20M.%20N.%2C%20Bozorgui%2C%20S.%20et%20al.%20%282016%29.%20Proximal%20Roux-en-y%20Gastrojejunal%20Anastomosis%20with%20Pyloric%20Ring%20Resection%20Improves%20Gastric%20Emptying%20After%20Pancreaticoduodenectomy.%20%26lt%3Bi%26gt%3BJ%20Gastrointest%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%2C%20914%26%23x2013%3B923.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11605-016-3091-5%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11605-016-3091-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Proximal%20Roux-en-y%20Gastrojejunal%20Anastomosis%20with%20Pyloric%20Ring%20Resection%20Improves%20Gastric%20Emptying%20After%20Pancreaticoduodenectomy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%20N.%22%2C%22lastName%22%3A%22Cagigas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shima%22%2C%22lastName%22%3A%22Bozorgui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%20F.%22%2C%22lastName%22%3A%22Ozaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Patrick%22%2C%22lastName%22%3A%22Wood%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Delayed%20gastric%20emptying%20%28DGE%29%20is%20a%20common%20complication%20of%20pancreaticoduodenectomy.%20We%20determined%20the%20efficiency%20of%20a%20new%20reconstruction%20technique%2C%20designed%20to%20preserve%20motilin-secreting%20cells%20and%20maximize%20the%20utility%20of%20their%20receptors%2C%20in%20reducing%20the%20incidence%20of%20DGE%20after%20pancreaticoduodenectomy.%5CnMETHODS%3A%20From%20April%202005%20to%20September%202014%2C%20217%20consecutive%20patients%20underwent%20pancreaticoduodenectomy%20at%20our%20institution.%20Nine%20patients%20who%20underwent%20total%20pancreatectomy%20were%20excluded.%20We%20compared%20outcomes%20between%20patients%20who%20underwent%20pancreaticoduodenectomy%20with%20resection%20of%20the%20pyloric%20ring%20followed%20by%20proximal%20Roux-en-y%20gastrojejunal%20anastomosis%20%28group%20I%2C%20n%5Cu2009%3D%5Cu200990%29%20and%20patients%20who%20underwent%20standard%20pancreaticoduodenectomy%20with%20the%20orthotopic%20reconstruction%20technique%20%28group%20II%2C%20n%5Cu2009%3D%5Cu2009118%29.%5CnRESULTS%3A%20Overall%20and%20clinically%20relevant%20rates%20of%20DGE%20were%20significantly%20lower%20in%20group%20I%20than%20in%20group%20II%20%2810%20and%202.2%5Cu00a0%25%20vs.%2057%20and%2024%5Cu00a0%25%2C%20respectively%3B%20p%5Cu2009%26lt%3B%5Cu20090.05%29.%20Length%20of%20hospital%20stay%20as%20a%20result%20of%20DGE%20was%20shorter%20in%20group%20I%20than%20in%20group%20II.%20In%20univariate%20analysis%2C%20older%20age%2C%20comorbidities%2C%20ASA%20grade%204%2C%20operative%20time%2C%20preoperative%20diabetes%2C%20standard%20reconstruction%20technique%2C%20and%20postoperative%20complications%20were%20significant%20risk%20factors%20for%20DGE.%20In%20multivariate%20analysis%2C%20older%20age%2C%20standard%20technique%2C%20and%20postoperative%20complications%20were%20independent%20risk%20factors%20for%20DGE.%5CnCONCLUSION%3A%20Our%20new%20reconstruction%20technique%20reduces%20the%20occurrence%20of%20DGE%20after%20pancreaticoduodenectomy.%22%2C%22date%22%3A%22May%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11605-016-3091-5%22%2C%22ISSN%22%3A%221873-4626%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A57%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22HEWNNKRP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Van%20Buren%20et%20al.%22%2C%22parsedDate%22%3A%222014-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVan%20Buren%2C%20G.%2C%20Bloomston%2C%20M.%2C%20Hughes%2C%20S.%20J.%20et%20al.%20%282014%29.%20A%20randomized%20prospective%20multicenter%20trial%20of%20pancreaticoduodenectomy%20with%20and%20without%20routine%20intraperitoneal%20drainage.%20%26lt%3Bi%26gt%3BAnn%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B259%26lt%3B%5C%2Fi%26gt%3B%2C%20605%26%23x2013%3B612.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000000460%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000000460%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20randomized%20prospective%20multicenter%20trial%20of%20pancreaticoduodenectomy%20with%20and%20without%20routine%20intraperitoneal%20drainage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Van%20Buren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Bloomston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%22%2C%22lastName%22%3A%22Winter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20W.%22%2C%22lastName%22%3A%22Behrman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Zyromski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Vollmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vic%22%2C%22lastName%22%3A%22Velanovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taylor%22%2C%22lastName%22%3A%22Riall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Muscarella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Trevino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Attila%22%2C%22lastName%22%3A%22Nakeeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20Max%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Behrns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Christopher%22%2C%22lastName%22%3A%22Ellison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Barakat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%20A.%22%2C%22lastName%22%3A%22Perry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Drebin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22House%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherif%22%2C%22lastName%22%3A%22Abdel-Misih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Silberfein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Goldin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somala%22%2C%22lastName%22%3A%22Mohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally%20E.%22%2C%22lastName%22%3A%22Hodges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22McElhany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Issazadeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eunji%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianxing%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20E.%22%2C%22lastName%22%3A%22Fisher%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20test%20by%20randomized%20prospective%20multicenter%20trial%20the%20hypothesis%20that%20pancreaticoduodenectomy%20%28PD%29%20without%20the%20use%20of%20intraperitoneal%20drainage%20does%20not%20increase%20the%20frequency%20or%20severity%20of%20complications.%5CnBACKGROUND%3A%20Some%20surgeons%20have%20abandoned%20the%20use%20of%20drains%20placed%20during%20pancreas%20resection.%5CnMETHODS%3A%20We%20randomized%20137%20patients%20to%20PD%20with%20%28n%20%3D%2068%2C%20drain%20group%29%20and%20without%20%28n%20%3D%2069%2C%20no-drain%20group%29%20the%20use%20of%20intraperitoneal%20drainage%20and%20compared%20the%20safety%20of%20this%20approach%20and%20spectrum%20of%20complications%20between%20the%202%20groups.%5CnRESULTS%3A%20There%20were%20no%20differences%20between%20drain%20and%20no-drain%20cohorts%20in%20demographics%2C%20comorbidities%2C%20pathology%2C%20pancreatic%20duct%20size%2C%20pancreas%20texture%2C%20baseline%20quality%20of%20life%2C%20or%20operative%20technique.%20PD%20without%20intraperitoneal%20drainage%20was%20associated%20with%20an%20increase%20in%20the%20number%20of%20complications%20per%20patient%20%5B1%20%280-2%29%20vs%202%20%281-4%29%2C%20P%20%3D%200.029%5D%3B%20an%20increase%20in%20the%20number%20of%20patients%20who%20had%20at%20least%201%20%5Cu2265grade%202%20complication%20%5B35%20%2852%25%29%20vs%2047%20%2868%25%29%2C%20P%20%3D%200.047%5D%3B%20and%20a%20higher%20average%20complication%20severity%20%5B2%20%280-2%29%20vs%202%20%281-3%29%2C%20P%20%3D%200.027%5D.%20PD%20without%20intraperitoneal%20drainage%20was%20associated%20with%20a%20higher%20incidence%20of%20gastroparesis%2C%20intra-abdominal%20fluid%20collection%2C%20intra-abdominal%20abscess%20%2810%25%20vs%2025%25%2C%20P%20%3D%200.027%29%2C%20severe%20%28%5Cu2265grade%202%29%20diarrhea%2C%20need%20for%20a%20postoperative%20percutaneous%20drain%2C%20and%20a%20prolonged%20length%20of%20stay.%20The%20Data%20Safety%20Monitoring%20Board%20stopped%20the%20study%20early%20because%20of%20an%20increase%20in%20mortality%20from%203%25%20to%2012%25%20in%20the%20patients%20undergoing%20PD%20without%20intraperitoneal%20drainage.%5CnCONCLUSIONS%3A%20This%20study%20provides%20level%201%20data%2C%20suggesting%20that%20elimination%20of%20intraperitoneal%20drainage%20in%20all%20cases%20of%20PD%20increases%20the%20frequency%20and%20severity%20of%20complications.%22%2C%22date%22%3A%22Apr%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FSLA.0000000000000460%22%2C%22ISSN%22%3A%221528-1140%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ALPULI85%22%5D%2C%22dateModified%22%3A%222023-07-27T15%3A58%3A28Z%22%7D%7D%5D%7D
Manisundaram, N., Portuondo, J. I., Erstad, D. et al. (2023). Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. J Am Coll Surg 236, 861–870. https://doi.org/10.1097/XCS.0000000000000549.
Michelakos, T., Kontos, F., Barakat, O. et al. (2021). B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert Opin Biol Ther 21, 587–602. https://doi.org/10.1080/14712598.2021.1862791.
Haider, M. A., Naqvi, S., Barakat, O. et al. (2021). Ampullary Carcinosarcoma with Enteroblastic Differentiation: A Case Report. Ann Clin Lab Sci 51, 131–135
Villafane-Ferriol, N., Baugh, K. A., McElhany, A. L. et al. (2019). Evidence versus practice in early drain removal after pancreatectomy. J Surg Res 236, 332–339. https://doi.org/10.1016/j.jss.2018.11.048.
Baugh, K. A., Tran Cao, H. S., van Buren, G. et al. (2019). Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery 165, 307–314. https://doi.org/10.1016/j.surg.2018.08.003.
Villafane-Ferriol, N., Shah, R. M., Mohammed, S. et al. (2018). Evidence-based management of drains following pancreatic resection: a systematic review. Pancreas 47, 12–17. https://doi.org/10.1097/MPA.0000000000000961.
Van Buren, G., Bloomston, M., Schmidt, C. R. et al. (2017). A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg 266, 421–431. https://doi.org/10.1097/SLA.0000000000002375.
Gilliland, T. M., Villafane-Ferriol, N., Shah, K. P. et al. (2017). Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients 9. https://doi.org/10.3390/nu9030243.
Barakat, O., Cagigas, M. N., Bozorgui, S. et al. (2016). Proximal Roux-en-y Gastrojejunal Anastomosis with Pyloric Ring Resection Improves Gastric Emptying After Pancreaticoduodenectomy. J Gastrointest Surg 20, 914–923. https://doi.org/10.1007/s11605-016-3091-5.
Van Buren, G., Bloomston, M., Hughes, S. J. et al. (2014). A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg 259, 605–612. https://doi.org/10.1097/SLA.0000000000000460.